Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
August 2, 2016 4:05 PM EDTMENLO PARK, CA -- (Marketwired) -- 08/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Second quarter revenue of $19.7 million, a 65 percent increase from the second quarter of 2015 Second quarter GAAP net income of $0.01 per share, compared to a GAAP net loss of $0.02 per share in the second quarter of 2015 Excluding non-cash expenses, second quarter non-GAAP net income of $0.03 per share, compared to non-GAAP net income of $0.00 per share in the second quarter of 2015 Cash balance at June 30 increases to $41.8 million Company reiterates its 2016 revenue guidance of $76-81 million... More